ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,128Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 1469

$1.07M Total Retail Price of All Prescriptions

Rank: 26 out of 1469

221 Patients Receiving at Least One Drug in Part D
94% Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

50% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%. This is far more than peers.

Prescription Price

$106 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
RANEXA 526 508 71 1 33
CARVEDILOL 516 479 68 2 2
CRESTOR 420 387 53 3 15
CLOPIDOGREL 377 372* 41 4 5
ATORVASTATIN CALCIUM 337 317 41 5 1
SPIRONOLACTONE 307 307 43 6 22
FUROSEMIDE 272 267* 39 7 8
NEXIUM 231 219 26 8 47
VALSARTAN-HYDROCHLOROTHIAZIDE 226 226 45 9 37
TRIBENZOR 215 210* 33 10 146
DEXILANT 196 184 30 11 84
METOPROLOL SUCCINATE 183 178* 28 12 4
BYSTOLIC 175 170* 23 13 29
TRAMADOL HCL 168 168 20 14 55
KOMBIGLYZE XR 157 138 25 15 252
DONEPEZIL HCL 155 155 19 16 66
VASCEPA 153 125 24 17 126
MECLIZINE HCL 149 144* 29 18 104
NAPROXEN 146 146 25 19 109
PIOGLITAZONE HCL 134 122 15 R 20 88
AMLODIPINE BESYLATE 134 122 23 20 3
ACEBUTOLOL HCL 132 127* 21 22 269
CELEBREX 126 114 13 23 81
DOXAZOSIN MESYLATE 116 104 13 24 58
DIOVAN 115 110* 14 25 14
LOVAZA 112 107* 21 26 42
EFFIENT 110 99 11 27 68
NAMENDA 105 105 15 28 78
JENTADUETO 102 102 15 29 235
ZOLPIDEM TARTRATE 101 101 13 30 34
ESCITALOPRAM OXALATE 98 98 12 31 86
TAMSULOSIN HCL 92 <11 <11 32 44
JANUMET 78 78 12 33 127
XARELTO 76 76 13 34 24
LEVOTHYROXINE SODIUM 75 <11 <11 35 21
DIOVAN HCT 70 65* 21 36 122
IBUPROFEN 69 <11 <11 37 92
TRADJENTA 68 <11 <11 38 171
CILOSTAZOL 68 68 11 38 93
EXFORGE HCT 66 <11 <11 40 183
VOLTAREN 65 <11 <11 41 80
GLIMEPIRIDE 64 <11 <11 42 63
BENICAR HCT 63 63 16 43 85
WARFARIN SODIUM 63 <11 <11 43 9
EDARBYCLOR 62 51 12 45 193
EXFORGE 62 <11 <11 45 89
PANTOPRAZOLE SODIUM 60 <11 <11 47 41
LORAZEPAM 58 <11 <11 B 48 60
LINZESS 57 57 15 49 222
MONTELUKAST SODIUM 56 <11 <11 50 70
METFORMIN HCL ER 55 <11 <11 51 176
OMEPRAZOLE 55 <11 <11 51 23
SINGLE USE SWAB 52 <11 <11 53 278
BENICAR 52 <11 <11 53 49
LOSARTAN-HYDROCHLOROTHIAZIDE 52 <11 <11 53 32
FAMOTIDINE* 52 <11 <11 53 61
BYDUREON 50 <11 <11 57 390
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.